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Summary 
To determine whether T cells, like B cells, can become clonally expanded in normal individuals 
as a function of age, we compared the T cell VB repertoire of cord blood to that of peripheral 
blood from normal donors over 65 yr of age. T cells from elderly subjects contained expanded 
subsets (greater than the mean + three standard deviations)  ofT cell receptor (TCR) VB populations. 
These expanded subsets were observed primarily among CDS, but not CD4 cells, represented 
up to 37.5% of all CD8 cells, and were present in most elderly subjects. An expanded V~5.2/3 
CD8 subset and a VB6.7a CD8 subset from separate donors were analyzed by reverse transcrip- 
tase-polymerase chain reaction, cloning and sequencing of the TCR ~ chain VDJ junction. In 
both cases the expanded subsets were mono- or oligoclonal while control CD4 populations were 
polyclonal. Using two-color flow cytometry it was possible to identify the expanded Vf36.7a 
subset as CD8 + CD28-CDllb + cells. In three of five random old subjects similar expansions 
of V~ subsets were found specifically  in the CD8 + CD28- subpopulation,  an interesting subset 
of cytotoxic T lymphocytes, known to lack proliferative responses to TCR stimuli. It is common 
practice to use the demonstration of  donality as a diagnostic indicator for T cell lymphoma/leukemia. 
In view of the high frequency of expanded T clones of T cells in normal elderly subjects the 
diagnostic  usefulness of this test should be reexamined. 
M 
onoclonal expansions of nonmalignant B cells occur 
frequently  in elderly individuals and can be readily de- 
tected due to the presence of monodonal immunoglobulin 
peaks on serum dectrophoresis, present in 10% of normal 
adults over 80 yr old (1). Clinically this condition is termed 
"Benign Monoclonal Gammapathy" and is thought to be a 
consequence of chronic stimulation of  B cells by stir-antigens 
or microbial antigens over a lifetime (2). We hypothesized 
that similar clonal expansions of T ceUs might occur in the 
dderly. Evidence is provided herein,  that donal TCR-cff~ 
cell populations  are frequent in normal subjects over age 65 
and that these are usually clones of CD8 + CD28-  calls. 
These data should help in evaluating the significance of  donal 
expansions of T cells in inflammatory and autoimmune dis- 
orders (3-13). In addition, the clinical utility of demonstrating 
donally expanded T ceils in support of a diagnosis of T cell 
malignancy (14) should be reexamined. 
Materiah and Methods 
Immunofluorescenc~  Indirect  immunofluorescence  was performed 
by incubating  cells for 40 min at 25~  with the primary unlabeled 
antibody (usually  an anti-TCR.  V~), followed  by washing the cells 
three times with PBS, BSA 1%, followed  by a 40-min incubation 
with  goat anti-mouse Ig Fab'2 FITC-labeled second antibody 
(Tago, Inc., Burlingame,  CA), washing  cells three times, a 40-min 
incubation with e~-ss mouse  IgG1, washing  three  times, and finally 
a 40-min  incubation  with PE-conjugated  anti-CD4 mAb, anti-CD3, 
anti-CD8 (Upstate  Biotechnology,  Inc., Lake  Placid, NY), or anti- 
CD28 (Becton  Dickinson & Co., Mountain View, CA). The pri- 
mary anti-TCK mAbs were $511-VB12, C37-VB5.2/3, OT145- 
V/56.7a, T't3a-V~8, C1-V~17, LCA-V~5.1, F1-Vc~2.3, 8F10-V~3 (15), 
and also included E22E7.2-V82 (16), V1313.1 (17), V~13.2 (17), 
V/313.3 (18), IG125-V/~21, and IMMU546-V/~22 both kindly do- 
nated by Dr. A. Necker  and Dr. F. Romagne (Immunotech, Mar- 
seine, France), and V~I  from Dr. O.  Kanagawa (Washington 
University,  St. Louis, MO). For the two-color  immtmofluorescence 
in Fig. 6 the goat anti-mouse  Ig Fab'2 antibody  was PE conjugated 
and the final antibody  was FITC-conjugated  OT145 (anti-V~6.7a). 
The primary mAbs were a negative control (IgG1), CD3 (clone 
454), CD4 (clone  FFB2.3), CD8cz (OKT8, CRL 8014; American 
Type Culture Collection [ATCC], Rockville, MD), HLA-DR 
(VG2.1, from Dr. S. M. Fu), CDllb (OKM1, CRL 8026; ATCC), 
anti-transferrin  receptor  (TRF, OKT9, CD71, CRL 8021; ATCC), 
CD45RA (4G10; from  Dr. K. Steinman, Rockefeller  University, 
New York), CD45RO (UCHL1), CD57 (HNK-1, TIB200; ATCC), 
Tac (CD25; from Dr. T. Waldman, National Institutes of Health, 
Bethesda, MD), CD28 (done NE-51, Becton Dickinson & Co.). 
Cells were analyzed  on an Elite flow cytometry system (Coulter 
Corp., Hialeah, FL). 
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rated by negative selection from StLBC-rosetted T  cells using the 
mAb followed by goat anti-mouse Ig-coated Dynabeads (Dynal 
Inc., Great Neck, NY). Populations were >90% purified. OT145 
positive cells (Vflr.7a) were isolated by positive selection using the 
same procedure and starting  with the purified CD4 and CD8 
subsets. This positive selection removed practically all OT145 + 
cells (Fig. 3 B). 
Molecular  Analysis of V~Subsets.  RNA was extracted from iso- 
lated ceils by RNAzol (Biotecx Lab., Inc., Houston, TX). cDNA 
was synthesized with routine reverse transcriptase. PCR was per- 
formed with predetermined optimal amounts of cDNA, primers 
at 200 riM, MgCI2 1.5 mM, dNTPs at 0.5 mM in 0.05 ml of 10 
mM Tris (pH 9 at 25~  50 ram KC1, 0.01% gdatin, 0.1% Triton 
X-100 (36 cycles of 94~  x  I min, 51~  x  1 min, 72~  x  1.5 
min, with a final 72~  x  10 min). The primers used were Vfl5.2/3: 
5' GTCAGGGGCCCCAGTTTAT Y (sense), Vfl6: 5' TCAGGT- 
GIGATCCAATTTC  3' (sense),  which amplifies all Vfl6 family 
members, and a Cfl primer: 5' CTTCTG~TCAAACAC  3' 
(antisense) (19). PCR products were Ilgated into the pCR2000 
vector (Invitrogen Corp., San Diego, CA) and INVI(xF' Escherichia 
coil were transformed. Transformants containing appropriate sized 
inserts were sequenced by the dideoxy chain termination method. 
Results 
In a survey of the effect of age on the Vfl repertoire we 
analyzed the frequency of CD3 + T  cells expressing Vf112, 
Vfl5.2/3, and Vfl6.7a in normal individuals grouped by age. 
There was no significant difference in Vfl expression between 
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Figure  1.  Percentages of Vfl subsets are more variable in the elderly. 
Normal donors were divided into three subsets by age (n  -  15 for each 
subset).  (tl) The mean percentage of cells expressing  the indicated Vfl 
does not differ significantly  fi'om one age group to another. (B) The stan- 
dard deviation of the mean is consistently higher in the older age groups. 
the groups of young, middle aged, or dderly subjects.  How- 
ever, the standard deviations of the mean were consistently 
higher in the group of dderly donors (Fig.  1). Thus varia- 
tion in the percentage of cells expressing a given Vfl gene 
increases with age within a population, which can be inter- 
preted as the effect of environmental influences on the Vfl 
repertoire. 
The frequency of T cells expressing 6 Vfl and 1 Vot gene 
was determined in CD4 and CD8 subsets from cord blood 
lymphocytes (n  =  12) and from lymphocytes obtained from 
donors over age 65 (n  =  11) (Table  1). To select outlying 
values  an arbitrary cutoff was used: the mean  +  3 SD of 
the Vfl percentage in either CD4 or CD8 cells, derived from 
cumulative data obtained on normal subjects ofaU ages, who 
had served as control populations in prior studies, n  =  48 
(15, 20). The only outlying values (above the mean +  3 SD) 
occurred among the CD8  cells  from 4  of 11  old donors 
(Table  1). 
This type of analysis was extended using a larger panel 
of TCP, mAb in seven further donors above the age of 65 
(Table 2). Expansions of Vfl subsets beyond the cutoff value 
were observed in five of seven donors, again primarily in the 
CD8 subset. Thus, the use of a larger panel of Vfl antibodies, 
covering "~35% of the total Vfl repertoire (15), demonstrates 
the high frequency of the observed expansions, highlighted 
in Tables 1 and 2, and suggests that these expansions occur 
in virtually all individuals as a function of age. 
Fluorescence histograms are shown for donor 15 (Fig.  2) 
and donor 18 (Fig.  3).  Donor 15 had three expanded Vfl 
subsets (13.0% Vfl5.2/3, 12.0% VflS, 11.5% Vf122) among 
the CD8 cells and one borderline expanded subset (10.4% 
Vfl6.7a) among the CD4 cells, each highlighted in Fig. 2. 
Donor 18 had a particularly large subset of  Vfl6.7a cells, 37.5% 
of CD8  ceils,  and an additional expansion of Vfl5.1 cells 
representing 20.9% of CD8 cells (Fig. 3 A). Repeated anal- 
),sis of both donors over a 6-mo period showed that these 
subsets remained constantly expanded. These two donors were 
chosen for further studies of the donality of the Vfl5.2/3 
subset (donor 15) and the Vfl6.7a subset (donor 18) by RT- 
PCR 1 and sequencing of the VDJ junction of the relevant 
Vfl chains. 
The CD8 ceils of donor 15 contain a Vf15.2 done repre- 
sented by 12 of 20 sequenced clones (Hg. 4). By contrast the 
Vfl5.2/3 clones obtained from the CD4 cells of the same 
donor, a nonexpanded subset (Fig. 2), were polydonal (Hg. 
4).  Even the CD4 cells from donor 15 that were cultured 
in vitro with IL-2 for 6 d remained polyclonal. 12 of 23 clones 
used the Vf15.3 gene segment and the rest used VflS.2 in 
the CD4 subset, while only 1 done derived from the CD8 
subset had a VflS.3 sequence. This indicates skewed represen- 
tation of these two Vfl genes in the CD8 cells of this in- 
dividual. 
The expanded Vfl6.7a CD8 subset from donor 18 was posi- 
1  Abbm,  iations used in this  paper: IEL, intestinal intraepithe~ lymphocytes; 
RT-PCR, reverse  transcriptase-polymerase chain reaction. 
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CD4  V~12  Vfl5.2/3  V/~6.7a  Vfl8  V,85.1  v~17  Vot2.3 
m  +  3 SD  5.7  5.5  10.6  7.3  13.1  14.1  6.5 
Cord blood 
1  2.1  2.1  4.2 
2  2.0  4.0  4.0 
3  1.2  0.0  1.2 
4  0.5  3.1  2.7 
5  2.2  2.8  4.8 
6  3.6  1.8  9.5 
7  2.8  3.2  4.9 
8  1.9  1.9  1.4 
9  2.4  5.0  5.7 
10  1.4  2.1  1.4 
11  2.4  2.7  5.1 
12  1.2  1.7  6.6 
El~rlys~j~ts 
1  0.8  1.8  3.9 
2  0.0  2.6  2.8 
3  1.7  2.3  2.8 
4  1.4  3.3  4.0 
5  0.7  2.5  5.9 
6  4.2  3.8 
7  2.9  3.8  7.7 
8  0.5  0.6  1.7 
9  0.3  0.0  3.6 
10  4.3  3.4  3.9 
11  1.9  1.9  0.0 
CD8  V~12  Vf15.2  Vfl6.7a 
m  +  3 SD  4.7  7.3  7.7 
4.2  2.1  3.2  2.1 
5.3  7.3  1.3  4.0 
1.2  2.3  3.5  2.3 
1.7  3.5  1.4  1.2 
4.2  1.3  4.0  3.6 
3.6  3.6  4.8  4.8 
5.7  7.8  3.6  2.3 
2.8  7.0  4.2  2.8 
7.0 
3.6  9.3  3.6 
5.5  7.1  4.7  3.5 
5.5  11.4  6.0  6.0 
2.2  2.5  8.0  3,5 
3.5  7.4  14.0  2.9 
2.8  3.7  7.7  3.8 
4.4  5.6  6.4  3.2 
4.6  5.9  4.9  3.4 
2.8  4.5 
5.7  5.3  5.7 
4.2  9.0  4.5  2.4 
2.0  2.3  1.0  2.7 
4.8  3.0  9.7  2.4 
2.7  3.4  3.9  1.5 
Vfl8  VflS.1  V~17  V~2.3 
9.2  9.7  13.2  8.9 
Cord blood 
1  1.0  4.1  1.0  3.1  1.0  4.1  3.1 
2  3.5  2.1  2.1  7.1  5.9  4.7  8.2 
3  4.5  6.0  4.5  1.5  3.0  4.5  7.5 
4  0.8  0.5  0.9  2.0  0.9  1.2  1.3 
5  0.6  2.5  1.7  2.4  2.8  3.2  4.8 
6  4.7  4.7  4.7  2.3  2.3  7.0  2.3 
7  0.3  2.5  2.0  6.4  3.1  3.1  4,2 
8  1.5  3.8  1.5  3.8  3.8  7.4  6.1 
9  3.6  3.6  1.3  7.2  3.6  12.4 
10  2.8  4.3  3.6  2.1  2.1  1.4 
11  1.2  4.2  3.0  6.0  4.5  5.4  0.6 
12  1.8  3.0  3.0  5.5  6.1  4.9  6.7 
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CD4  VB12  V/~5.2/3  V/~6.7a  VB8  VB5.1  V/~17  Vo~2.3 
m  +  3SD  5.7  5.5  10.6  7.3  13.1  14.1  6.5 
Elderly suhj~ts 
1  0.3  1.5  2.1  0.0  0.3  5.6  2.1 
2  0.6  1.1  2.1  2.9  16.1  3.8  2.6 
3  0.2  2.7  0.0  2.0  2.0  1.8  0.0 
4  0.7  0.5  2.9  2.3  1.5  2.3  1.4 
5  0.0  1.1  1.1  2.6  2.6  0.4  1.9 
6  27.4  4.6  5.1  9.0  0.3  17.0 
7  0.6  5.5  7.3  3.7  0.6  7.9  2.0 
8  0.6  1.2  0.3  3.1  3.2  14.7  1.3 
9  1.4  0.4  1.6  3.4  3.8  1.0  1.6 
10  0.0  10.1  1.7  3.4  5.1  6.8 
11  0.0  1.8  0.0  1.8  2.6 
The numbers indicate percentages of CD4 + (or CD8 +), CD3 + T cells that express the indicated  V/3. Values above the mean +  3 SD are boldfaced. 
tively sdected with mAb OT145 and goat anti-mouse-coated 
magnetic beads. As seen in Fig. 3 B, the remaining CD8 cells 
from donor 18 were depleted of the large V/36.7a subset but 
not  of other  VB  subsets,  indicating high efficiency and 
specificity of the positive selection. Cellular RNA was then 
isolated from the selected ceils, reverse transcribed and used 
for a PCR with a pan-VB6 sense primer and a CB anti-sense 
primer. Here also a large fraction of the sequenced clones 
Table 2.  Extended  V~ Analysis  in Elderly Subjects 
CD4  V/~12  V/~5.2/3  V/36.7a  VB8  V/35.1  VB17  VB2  VB13.1  VB13.2  VB13.3  VB22  V~21  VB3 
m  +  3 SD  5.7  5.5  10.6  7.3  13.1  14.1  13.2  9.0  6.7  12.6  9.9  2.9  9.4 
12  2.2  2.2  6.0  4.1  5.3  5.9  8.3  4.0  4.4  4.9  2.0 
13  1.0  7.6  1.2  8.8  4.8  2.8  6.8  2.8  0.4  4.6  2.2  2.0  5.0 
14  1.2  3.6  4.6  5.2  5.6  5.6  8.2  4.4  3.0  7.6  4.0  2.4  5.4 
15  1.2  2.6  10.4  4.8  5.4  6.4  6.8  7.2  2.6  9.8  3.2  2.4  3.6 
16  1.6  0.1  4.3  5.2  4.4  5.5  11.1  4.1  2.2  5.9  3.2  2.5  6.2 
17  2.1  0.1  1.0  4.6  7.5  5.8  9.4  4.5  0.5  5.8  7.6  2.3  4.1 
18  2.4  1.4  7.6  5.7  5.0  4.3  1.4 
CD8  V~12  V~5.2/3  V~6.7a  V~8  V~5.1  VB17  VB2  VB13.1  V~13.2  VB13.3  VB22  V~21  V~3 
m  +  3SD  4.7  7.3  7.7  9.2  9.7  13.2  6.6  13.7  8.6  14.9  6.9  6.3  7.2 
12  3.1  4.6  9.2  7.7  3.1  10.8  4.6  4.6  6.2  4.6  4.6 
13  0.7  4.7  0.7  2.7  2.0  5.3  2.0  10.7  0.7  10.7  4.0  2.7 
14  1.0  1.0  4.0  2.0  1.0  5.0  2.0  6.0  1.0  6.0  2.0  1.0  4.0 
15  1.0  13.0  2.0  12.0  2.0  3.0  4.0  3.5  2.5  4.5  11.5  1.0  3.5 
16  1.0  0.5  1.4  2.0  1.8  8.0  3.4  4.0  1.0  4.0  3.8  2.0  4.4 
17  1.0  0.5  0.5  3.0  22.0  2.0  4.0  3.0  0.5  4.0  2.0  1.0  1.0 
18  1.3  1.3  37.5  20.9  2.5  0.6  2.2 
The numbers indicate percentages of CD4 § (or CD8 +), CD3 * T cells that express the indicated V/3. Values above the mean +  3 SD are boldfaced. 
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Figure  2.  Fhorescence histograms from donor 
15. In the top panel staining with the indicated 
V~ antibodies is shown for the CD4 subset (anal- 
)'sis gates set on CD4-PE positive cells). In the 
bottom panel staining is shown for the CD8 subset. 
The highlighted peaks represent expanded subsets 
(see data in Table 2). 
(9 of 17) represents a dominant V~6.7a clone, and a second 
group of clones (3 of 17) represents another aloha1 popula- 
tion of V~6.Ta ceils (Fig.  5). Both of these clones are not 
expanded among the CD4 cells from this donor (data not 
shown). 
To further characterize the expanded V~6.7a subset in donor 
18, two-color immunofluorescence  was performed with the 
V~-specific mAb, OT145, directly labded to FITC (Fig. 6). 
The V~6.7a cells were CDllb +, in part CD45RO +, and 
in  part  CD45RA +,  but  CD71-,  CD25-,  HLA-DR-, 
CD57-, and CD28-. There appeared to be two populations 
of CD8c~ + cells (arrows in Fig.  6).  The more prominent 
population stained intensdy with the CDga mAb consis- 
tent with prior data showing high levels of CDgc~ and low 
levels of CD8~  expression  on  CD8 +  CD28-  cells  (21). 
Negatively selected  CD8 +  calls  from donor  18  failed  to 
proliferate in vitro in response to the OT145 mAb but did 
respond to anti-CD3 (data  not shown). Thus, the pheno- 
Figure  3.  Fluorescence  histograms from donor 18. (A) Analysis ofnega- 
tivdy selected CD8 cells, demonstrating an expanded subset of OT145- 
V~6.7a cells and of I.C4-V~5.1 cells (see Table 2). (B) Reanalysis of the 
same CD8 cells after the O1"145 cells were removed by positive sdection 
with goat anti-mouse Ig-coated magnetic beads, demonstrating specific 
and nearly complete  removal. A 
n  v~  D~  J~ 
C  A  S  S 
1  V~5.2  TGTGCCAGCAGC 
C  A  S  S  L  N  P  R 
1  V~5.3  TGTGCCAGCAGCTTG  AATCCC.C_@A 
C  A  S  S  L  E  S  R  G  V 
1  V~5.3  TGTGCCAGCAGC  CTGGAAAGCCGGGGGGTAT 
C  A  S  S  L  K  S 
1  V~5.3  TGTGCCAGCAGCTTG  AAAAGC 
C  A  S  S  L  T  P  G  Q  G 
1  V~5.3  TGTGCCAGCAGCTTG  ACCCCGGGTCAGGG 
C  A  S 
1  V~5.2  TGTGCCAGC 
C  A  S  R 
1  VB5.3  TGTGCCAGCAG 
C  A  S  S 
1  V~5.3  TGTGCCAGCAGC 
C  A  S  S 
1  V~5.2  TGTGCCAGTAGC 
C  A  S  S 
1  V~5.2  TGTGCCAGCAGC 
P  W  T  P  E  G  S  Y  N  S  P  L  H  F  G 
CCATGGACTCCGGAAGGG  TCCTATAATTCACCTCTCCACTTTGGG  J~  1  .  6 
A  A  Q  T  S  G 
GCCGCCCAGACTAGCGG 
G  M  G  S  L 
GGGAATGGGGTCTCT 
N  D  G  S 
AATGACGGGAG 
P  R  D  S 
CCCCGGGACAGTA 
P  P  N  I 
CCTCCGAATATTG 
C  A  S  S  L  K  L  N 
1  V~5.2  TGTGCCAGCAGCTTG  AAACTGAAC 
C  A  S  S  L  I  S  R  G  N 
1  V~5.2  TGTGCCAGCAGCTTG  ATCTCCCGAGGGAA 
C  A  S  S  G  W  T  S  P  R 
1  V~5.2  TGTGCCAGCAGC  GGGTGGACTAGTCCTCG 
S  Y  E  Q  Y  F  G 
TCCTACGAGCAGTACTTCGGG  J~2.7 
TACAATGAGCAGTTCTTCGGG  J~2.1 
N  T  G  E  L  F  F  G 
AACACCGGGGAGCTGTTTTTTGGA  J~2.2 
D  T  Q  Y  F  G 
AGATACGCAGTATTTTGGC  J~2.3 
Q  E  T  Q  Y  F  G 
CCAAGAGACCCAGTACTTCGGG  J~2.5 
Y  E  Q  Y  F  G 
CTACGAGCAGTACTTCGGG  J~2.7 
N  E  K  L  F  F  G 
TAATGAAAAACTGTTTTTTGGC  J~l.4 
T  Y  E  Q  Y  F  G 
CCTACGAGCAGTACTTCGGG  J~2.7 
D  N  E  Q  F  F  G 
ACAATGAGCAGTTCTTCGGG  J~2.1 
N  Y  G  Y  T  F  G 
AACTATGGCTACACCTTCGGT  J~l.2 
Y  E  Q  Y  F  G 
CTACGAGCAGTACTTCGGG  J~2.7 
T  Q  Y  F  G 
GACCCAGTACTTCGGG  J~2.5 
C  A  S  S 
1  V~5.3  TGTGCCAGCAGC 
C  A  S  S 
1  V~5.3  TGTGCCAGCAGCT 
C  A  S  S 
1  V~5.3  TGTGCCAGCAGC 
C  A  S  S  F 
1  V~5.2  TGTGCCAGCAGCTT 
C  A  S  S 
1  V~5.3  TGTGCCAGCAGC 
P  K  G  V 
CCGAAGGGAGT 
W  R  D  R  G  F 
GGAGGGACAGGGGATT 




R  T  D  S 
CGGACGGACAGTG 
C  A  S  S  L  R  T  S  G  A  G 
1  V~5.3  TGTGCCAGCAGCTTG  AGGACTAGCGGGGCGGG 
C  A  S  R  P  A  G 
1  V~5.2  TGTGCCAGCAG  GCCGGCGGGG 
C  A  S  S  L  P  P  G  Q  G 
1  V~5.2  TGTGCCAGCAGCTT  ACCTCCGGGACAGGG 
C  A  S  S  L  R  G 
1  V~5.3  TGTGCCAGCAGCTTG  AGAGGGC 
C  A  R  S  R  G  S  D  R  D  F 
1  V~5.5  TGTGCCAGAAGC  AGGGGATCCGACAGAGATTTCG 
Y  E  Q  Y  F  G 
CTACGAGCAGTACTTCGGG  J~2.7 
Y  G  Y  T  F  G 
CTATGGCTACACCTTCGGT  J~l.2 
GAGACCCAGTACTTCGGG  J~2.5 
N  E  K  L  F  F  G 
TAATGAAAAACTGTTTTTTGGC  J~l.4 
A  Q  Y  F  G 
CGCAGTATTTTGGC  J~2.3 
D  T  Q  Y  F  G 
AGATACGCAGTATTTTGGC  J~2.3 
GAACACTGAAGCTTTCTTTGGA  J~2.1 
Q  F  F  G 
GCAGTTCTTCGGG  J~2.1 
H  E  Q  F  F  G 
ATGAGCAGTTCTTCGGG  J~2.1 
D  Q  P  Q  H  F  G 
ATCAGCCCCAGCATTTTGGT  J~l.5 
B 
n  V~  D~  J~ 
C  A  S  A  A  Q  T  S  G 
12  V~5.2  TGTGCCAGC  GCCGCCCAGACTAGCGG 
C  A  S  S  S  G  G  A  L 
1  V~5.2  TGTGCCAGC  TCTAGCGGGGGGGCTCT 
C  A  S  S  L  V  G  G 
1  V~5.2  TGTGCCAGCAGCTTG  GTAGGGGG 
C  A  ~  I  G 
1  V~5.3  TGTGCCAGCA  TAGGGG 
C  A  S  S  L  F  P  V  G  S 
1  V~5.2  TGTGCCAGCAGCTTG  TTCCCCGTGGGATCC 
C  A  S  S  L  E  D  G  G  L  K  F 
1  V~5.2  TGTGCCAGCAGCTTG  GAGGACGGGGGCCTAAAATTC 
C  A  S  R  G  Q  G 
1  V~5.2  TGTGCCAGCAG  GGGACAGGGT 
C  A 
1  V~5.2  TGTGC 
C  A  S  S 
1  V~5.3  TGTGCCAGCAGCT 
Q  E  T  Q  Y  F  G 
CCAAGAGACCCAGTACTTCGGG  J~2.5 
N  E  Q  F  F  G 
CAATGAGCAGTTCTTCGGG  J~2.1 
E  T  Q  Y  F  G 
AGAGACCCAGTACTTCGGG  J~2.5 
A  D  T  Q  Y  F  G 
CAGATACGCAGTATTTTGGC  J~2.3 
D  T  Q  Y  F  G 
GATACGCAGTATTTTGGC  J~2.3 
T  D  T  Q  Y  F  G 
ACAGATACGCAGTATTTTGGC  J~2.3 
S  Y  N  E  Q  F  F  G 
TCCTACAATGAGCAGTTCTTCGGG  J~2.1 
S  S  Q  R  G  L  P  G  E  T  Q  Y  F  G 
TTCGAGCCAGCGGGGGTTACCGGGG  GAGACCCAGTACTTCGGG  J~2.5 
S  S  G  T  P  G  D  Y  E  Q  Y  F  G 
CCTCCGGGACTCCCGGTGA  CTACGAGCAGTACTTCGGG  J~2.7 
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9  Vfl6 
3  vfl6 
z  v~6 
z  v~6 
z  v~6 
z  vfl6 
z  vfl6 
C  A  S  E  D  P  P  H  D  E  Q  F  F  G 
7a  TGTGCCAGC  GAGGACCCCCCCCACG  ATGAGCAGTTCTTCGGG  Jfl2.1 
C  A  S  S  L  V  T  G  Q  S  S  P  L  H  F  G 
7a  TGTGCCAGCAGCTTAG  TGACAGGGCAGAG  TTCACCCCTCCACTTTGGG  J~l.6 
C  A  S  S  R  A  D  N  Y  G  Y  T  F  G 
7a  TGTGCCAGCAGC  CGGGCCGAC  AACTATGGCTACACCTTCGGT  J~l.2 
C  A  S  S  L  A  G  G  A  S  G  N  T  I  Y  F  G 
7a  TGTGCCAGCAGCTT  GGCAGGGGGCGC  CTCTGGAAACACCATATATTTTGGA  Jill.3 
C  A  S  S  R  G  D  N  Y  G  * 
7a  TGTGCCAGCAGC  CGGGGGGAC  AACTATGGCTA  CCTTCGGT  J~l.2 
C  A  A  G  P  G  G  R  * 
4  TGTGC  GGCAGCCGCGGGAGGGCGGT  TACGAGCAGTACTTCGGG  J~2.7 
C  A  S  S  A  V  A  N  Q  P  Q  H  F  G 
.4  TGTGCCAGCAGC  GCCGTTG__CCA  AATCAGCCCCAGCATTTTGGT  J~l.5 
Figure  5.  Sequence analysis of CD8 * OT145 * cells from donor 18 demonstrating a major dominant Vfl6.7a  clone (sequenced nine times)  and 
a minor Vfl6.Ta clone (sequenced three times). Sequences that match genomic D~I or D~2 are underlined.  The asterisk denotes a frame shift. Possible 
P nucleotides  are in bold. 
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Figure  6.  Two-color  immunofluores- 
cence of peripheral blood lymphocytes from 
donor 18. OI"145 (anti-V~5.7a) was dktcdy 
labeled with HTC. All other mAbs (indi- 
cated in each pand) were indizcctly labeled 
with PE. The percentages of cells arc indi- 
cated in each quadrant.  Arrows point to 
the two CD8 + Vfl6.7a + populations,  to 
the CDllb +  Vfl6.7a +  cells and  to  the 
CD45RA +  Vfl6.Ta +  cells. Hardly  any 
Vfl6.7a  cells were CD28 + . 
type of the expanded Vfl6.7a cells of donor 18 resembles that 
of CD8 +,  CD28-  T  calls,  which  coexpress  CDllb,  use 
CDScvv preferentially,  and lack  proliferative  responses  to 
CD3/TCK stimuli (21). 
To determine whether the expanded CD8 + clones were 
commonly  CD28-,  five  random  dderly  subjects  were 
screened with 13 Vfl-specific antibodies. In three of five sub- 
jects expanded Vfl subsets were detected in CD8 cells iso- 
lated by negative sdection (donors S, P, and GP, in Table 
3).  In each case the expanded V~ subsets  had the CD8 + 
CD28- phenotype as determined by two-color flow cytom- 
etry with a PE-conjugated CD28 mAb (Table 3). As an in- 
Figure 4.  Sequence analysis of (,4) CD4 Vfl5.2/3 cells and (B) CD8 Vfl5.2/3 cells from donor 15. In A  the top 13 sequences are derived from 
fresh CD4 cells, while the bottom 10 sequences are from CD4 cells cultured with IL,2 for 6 d.  In B half of the sequences come from fresh CD8 
cells and half from IL2 cultured cells. The dominant Vf15.2 clone was sequenced six times from fresh cells and six times from cultured cells. The 
dominant CD8 clone was also found in a single sequence from the CD4 subset (6th seq~,acefrom  the top in A), presumably because of contamination 
of the CD4 subset with some of these ~panded CD8 cells. Sequences that match genomic Dill or Dfl2 are underlined.  The asterisk denotes a frame 
shift.  Possible P nuclentides  are in bold. 
615  Posnett  et al. Table  3.  V~ Repertoire Among  CD8 Subsets 
V/~I  V~5.2/3  Vfl8  V1313.1  V/313.2  V~17  Vf122 
Donor S 
CD3 +  0.7  0.3  6.2  6.8  2.3  5.8  2.7 
CD3 + 8 +  2.0  1.4  21.0  7.6  3.5  6.8  2.9 
CD3 + 8 + 28 +  0.9  0.9  2.8  6.0  3.0  7.2  2.8 
CD3 + 8 + 28 -  3.8  2.5  31.3  12.5  3.8  5.0  5.0 
Donor P 
CD3+  0.7  0.3  3.1  5.5  1.6  5.1  1.4 
CD3 + 8 +  0.3  0.3  0.8  15.3  6.4  3.0  0.5 
CD3 + 8 + 28 +  0.5  0.0  0.5  0.5  1.5  5.0  1.5 
CD3 + 8 + 28 -  0.3  0.3  0.3  16.6  6.0  2.7  0.0 
Donor GR 
CD3+  1.5  4.3  3.1  3.8  2.2  5.4  3.8 
CD3 + 8 +  6.1  2.4  2.7  2.0  2.0  13.4  4.6 
CD3 + 8 + 28 +  2.5  4.0  4.0  5.0  1.0  4.0  3.5 
CD3 + 8 + 28 -  12.9  1.7  0.0  0.8  0.8  18.3  4.2 
Donor GA 
CD3 +  1.6  5.8  3.3  6.7  2.2  6.7  3.3 
CD3 + 8 +  0.7  2.0  4.0  5.0  2.0  7.2  2.3 
CD3 + 8 + 28 +  1.1  0.0  4.6  5.4  2.1  6.8  3.6 
CD3 + 8 + 28 -  1.0  0.8  1.7  0.0  1.7  4.2  0.0 
Donor C 
CD3 +  0.4  1.8  4.6  6.8  0.7  6.4  3.8 
CD3 + 8 +  2.0  2.4  2.0  7.5  0.6  2.4  1.4 
CD3 + 8 + 28 +  1.7  2.8  1.7  6.1  0.6  3.3  1.1 
CD3 + 8 + 28 -  2.0  1.6  2.4  11.6  0.4  0.4  0.0 
vB percentages represent fractions of total CD3 § cells, of CD3 +  8 + cells, of CD3 +  8 +  28 + cells, or of CD3 +  8 §  28 - cells. Purified CD8 populations 
(containing <2% CD4 cells) were analyzed by two-color flow cytometry. The percentages of CDS+CD3 + cells over total CD3 + cells were for 
donor S, 28.9%; donor P, 23.1%; donor GR, 16.9%; donor GA, 21.6%;  and donor C, 16.0%. The distribution of CD28 among the CD8 cells of 
the five donors was for donor S: 85/15  (CD28+/CD28-); donor P: 40/60; donor GR: 45/55;  donor GA: 70/30; and donor C: 42/58.  VB subsets 
that are dearly expanded in the CD8 subset are boldfaced. Results with six additional Vl3-specific antibodies did not show any further expansions 
of VB subsets (data not shown). 
ternal control, other nonexpanded Vfl subsets were usually 
equally represented or decreased among CD8 + CD28- cells 
as compared with  CD8 +  CD28 + cells. 
Discunion 
Herein we show that normal elderly donors frequently have 
expanded Vfl subsets and that these are primarily found among 
CD8 +  CD28-  cells.  In two donors the expanded  subsets 
were analyzed by RT-PCR and sequencing, demonstrating 
that they represent clonally expanded populations of T  cells. 
Clonal expansions  of TCK-c~/fl T  cells  in man are fre- 
quently observed at the tissue sites of chronic inflammatory 
disorders including rheumatoid arthritis (6, 7), multiple scle- 
rosis (3-5), and leprosy reversal reactions (13). Similar studies 
have shown oligoclonality in the ~,//~ T cell subset (9-11), 
which was studied in multiple sclerosis and leishmaniasis. We 
have  followed  a  72-yr-old  patient  with  immune  throm- 
bocytopenia and a TCR-odfl done (VB6.Ta) in the periph- 
eral blood represented by a dominant TCR fl chain rearrange- 
ment. The donal cells  are CD8 § , represent about 20-30% 
of all CD3 cells and have remained present over several years 
without malignant transformation (12). The presence ofdonal 
T cell populations in normal individuals should result in con- 
straint  in the interpretation  of donal T  cell  populations in 
disease states. Without functional data on antigen/MHC re- 
activity the presence of a clone of T  cells at the site of an 
immune response is not necessarily linked to the pathogen- 
esis of the  disease. 
In addition, the donal populations in normal subjects ap- 
pear to persist over time and show no signs of transforma- 
tion to malignancy (12,  22,  23).  They may represent  rela- 
616  Clonal Populations of T Cells in Normal Elderly Humans tively large populations of donal T  cells easily detected by 
Southern blotting or PCR techniques. Analysis ofT cell clo- 
nality by these techniques is used clinically as an aid in the 
diagnosis of malignancy (14). Caution must therefore be ad- 
vised in the interpretation of the presence of donal T  cell 
populations. 
Prior studies on patients with expansions of large granular 
lymphocytes (LGL), also called T3,-lymphoproliferative dis- 
ease, have demonstrated frequent clonal expansions mostly 
among TCR-ot/fl CD8 + T cells (24, 25). These patients are 
often anemic, have splenomegaly, and abnormal white blood 
call counts. They may also have an associated  autoimmune 
disease. None of the normal donors investigated herein had 
signs of this disorder and their peripheral blood counts and 
peripheral blood smears were considered normal. Neverthe- 
less, one may speculate that patients with TT-lymphoprollfera- 
tire disease have exaggerated CD8 immune responses that 
are similar to the clonal expansions among normal subjects 
described herein. 
Previous studies demonstrate that T cells from normal in- 
dividuals may contain expanded clones, which can be detected 
if special subpopulations are examined. For instance, human 
intestinal intraepithelial lymphocytes (IEL) are frequently 
oligoclonal (26-28), presumably due to chronic stimulation 
by food and microbial antigens in the gut. Human IEL are 
primarily CD8 +  TCR-otlfl  T  lymphocytes.  A  subset  of 
human CD8 + IEL are known to express CD8otc~ homo- 
dimers rather than the more usual CD8ot~ heterodimers (ref- 
erence 26,  personal communication from P. Poussier), but 
CD28  expression by these cells has not yet been studied. 
Human  IEL  do  not  proliferate  in  vitro  in  response  to 
TCR/CD3  stimuli (29), although this may depend on the 
availability of integrins expressed uniquely by intestinal APCs 
(30). Thus, there are several similarities between CD8 + IEL 
and the CD8 + CD28-  subset in peripheral blood (21). The 
latter is absent in cord blood but accumulates variably in adults, 
in which it may represent 1-15%  of PBMCs (14).  In view 
of the results on subject 18 (Figs. 5, 6) and the results with 
three of five  random elderly subjects  (Table  3),  it  is the 
CD8 +  CD28-  subset  in  the  blood  that  is  frequently 
oligoclonal. It is possible that this PBL subset represents CD8 
cells derived from the IEL population, consistent with the 
absence of a thymus in dderly individuals and the known 
potential of the gut to serve as a thymic equivalent for matu- 
ration of ot/fl T  cells (31). 
Two further small subsets of normal adult T cells have been 
shown to be oligoclonal. CD4-8-  cx/fl T  cells, which are 
capable of recognizing bacterial antigens, are often oligodonal 
(22, 32) and the expanded dones may persist for several years 
(22).  Lastly, V/~I + 3'//~ T  cells are polyclonal at birth, but 
become oligodonal in adults (33). The latter subset are also 
the predominant ~//i T  cells in the gut (34). 
The  presence  of  clonal  expansions  primarily  among 
CD8 + CD28-  cells, suggests that these cells are specific for 
MHC class I-restricted antigens in vivo. Since these are com- 
mouly intracellular antigens of viral origin, we postulate that 
the expanded dories represent cytotoxic T cells with specificity 
for antigens of ubiquitous viruses (EBV, CMV, influenza, etc.). 
CD8 + CD28-  cells have been shown to lack proliferative 
responses to CD3/TCP,  stimuli and display high CTL ac- 
tivity in a redirected cytotoxidty assay anti-CD3-coated target 
cells (21). Therefore it is possible that repeated exposure to 
MHC class I-restricted antigens results in donal accumula- 
tion of endstage mature CTL. Dramatic accumulation of CD8 
cells has been observed in vivo with mice immunized with 
human class I transfected cells, in which reactive CD8 clones 
may represent over 50%  of T  lymphocytes (35) and show 
donally restricted diversity of TCP, chains (36). Human CTL 
lines derived in vitro with influenza peptide presented by 
HLA-A2 are also oligoclonal and use a restricted TCIL reper- 
toire (37). An alternative hypothesis is that the expanded CD8 
clones represent autoreactive cells, just like the benign mono- 
clonal gammapathies that frequently represent autoreactive 
specificities (2). Autoreactive T calls may be increased in fre- 
quency in old mice (38) and it has been suggested that the 
increased expression of HLA dass I that occurs with age may 
lead to autoreactivity (39). Both hypotheses can be tested using 
the expanded Vfl T  cdl populations described herein. 
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